News: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

1:35pm EDT
Price Change (% chg)

$-0.29 (-2.43%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks
Select another date:

Fri, Aug 15 2014

Achillion's hepatitis C drug shows promise in trial

- Achillion Pharmaceuticals Inc said all patients treated with its experimental hepatitis C drug showed no detectable levels of the virus four weeks after the therapy, sending its shares up 18 percent.

UPDATE 1-Achillion's hepatitis C drug shows promise in trial

(Adds details, analysts' comments on data, share movement)

Achillion's hepatitis C drug cures all patients in mid-stage trial

Aug 15 - Achillion Pharmaceuticals Inc said interim results from a mid-stage trial showed that all patients given its experimental hepatitis C drug showed no detectable levels of the virus four weeks after completing the therapy.

US STOCKS-Wall St ends near flat; Dow hits record for 4th day

* Dow up 0.02 pct, S&P 500 down 0.02 pct, Nasdaq up 0.04 pct (Updates to close)

US STOCKS-Wall St dips after string of recent Dow, S&P records

* Dow down 0.1 pct, S&P 500 down 0.1 pct, Nasdaq down 0.1 pct (Updates to late afternoon, changes byline)

US STOCKS-Wall St dips, stays near record peaks; incentives scant

* Dow, S&P 500 and Nasdaq all fall 0.1 pct (Updates to midday trading)

US STOCKS-Wall St recedes modestly from record levels

* Indexes down: Dow 0.2 pct S&P 500 0.3 pct, Nasdaq 0.3 pct (Updates to open)

US STOCKS-Futures point to early drop from record levels

* Futures down: Dow 20 pts, S&P 4.4 pts, Nasdaq 8.25 pts (Updates prices, adds RadioShack)

FDA lifts hold on Achillion's hepatitis C drug, shares jump

June 10 - Achillion Pharmaceuticals Inc said the U.S. Food and Drug Administration allowed it to resume the development of one of its hepatitis C drugs, lifting a clinical hold that was imposed nearly a year ago.

US STOCKS-Futures dip, S&P 500 comes off 4th straight record

NEW YORK, June 10 - U.S. stock index futures edged lower on Tuesday, as investors found few reasons to keep buying with the Dow and S&P 500 just off the latest in a string of records.

Select another date:
Search Stocks